Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Deepjyoti. Saikia"'
Publikováno v:
International Journal of Science and Healthcare Research. 8:136-144
Jemperli (dostarlimab) is an anti-PD-1 mab used to treat endometrial cancer. It is a humanized mab produced using rdna technology in CHO cells. It is approved in the US and EU and was developed by Tesaro, later acquired by GlaxoSmithKline. Clinical t
Autor:
Sanatkumar Nyamagoud, Pooja Mahajan, A Aswathi, Kadambari Patil, Lizanne Fernandes, Akash Chathamvelli, Deepjyoti. Saikia
Publikováno v:
Journal of Drug Delivery and Therapeutics. 13:76-83
Background: Diabetes is one of the most common diseases compared to others. There are many drugs available in the market to treat diabetes. Still, most of them have adverse drug reactions like hypoglycemia, weight gain, and subtherapeutic drug concen
Autor:
Deepjyoti Saikia
Publikováno v:
Journal of Drug Delivery and Therapeutics. 12:185-191
Cannabinoids are the most commonly recognized herbal plant, having much medicinal importance from ancient times and plays an important role in Indian culture. Now a day’s cannabinoids are used for many therapeutic purposes, and under clinical trial